NCT02037477View on ClinicalTrials.gov

Phase 3 Study to Evaluate the Acid-Inhibitory Effect of Multiple Oral Doses of Vonoprazan (TAK-438)

PHASE3CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions
Healthy Volunteers
Interventions
DRUG

Vonoprazan

Vonoprazan tablets

DRUG

Esomeprazole

Esomeprazole capsules

DRUG

Rabeprazole sodium

Rabeprazole sodium tablets

Trial Locations (1)

Unknown

Fukuoka

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY